Please see Important Safety Information on page 10 and Prescribing Information on pages 13 and 14.Supported by A Supplement to UDENYCA® (pegfilgrastim-cbqv) Faculty Jorge García, PharmD, MS, MHA, MBA, FACHE Assistant Vice President System Oncology Pharmacy Service Line Baptist Health South Florida Miami, Florida Introduction to Biosimilars In the United States, biosimilars are approved for use based on data exhibiting that they are highly similar and have no clinically meaningful
NOVEMBER 20, 2020